Daiwa Securities Group Inc. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 217 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
Daiwa Securities Group Inc. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$11
-26.7%
4260.0%0.00%
Q2 2023$15
+36.4%
4260.0%0.00%
Q1 2023$11
-35.3%
4260.0%0.00%
Q4 2022$17
-99.9%
426
+8.1%
0.00%
Q3 2022$13,000
-7.1%
3940.0%0.00%
Q2 2022$14,0000.0%394
+29.2%
0.00%
Q1 2022$14,000
-30.0%
3050.0%0.00%
Q4 2021$20,000
-9.1%
305
-14.6%
0.00%
Q3 2021$22,000
+29.4%
357
+73.3%
0.00%
Q2 2021$17,000
+21.4%
2060.0%0.00%
Q1 2021$14,000
-6.7%
206
+6.7%
0.00%
Q4 2020$15,000
-40.0%
193
-66.8%
0.00%
Q3 2020$25,000
+56.2%
581
+2.7%
0.00%
Q2 2020$16,0000.0%5660.0%0.00%
Q1 2020$16,000
-52.9%
566
+4.8%
0.00%
Q4 2019$34,000
+100.0%
540
-9.8%
0.00%
Q3 2019$17,000
+6.2%
5990.0%0.00%
Q2 2019$16,000
+45.5%
5990.0%0.00%
Q1 2019$11,000
+83.3%
599
+25.6%
0.00%
Q4 2018$6,000
-33.3%
4770.0%0.00%
Q3 2018$9,000
+50.0%
4770.0%0.00%
Q2 2018$6,000
+100.0%
4770.0%0.00%
Q1 2018$3,0004770.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2019
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,303$54,386,00028.54%
JOHNSON & JOHNSON 3,260,869$216,196,00024.61%
ACT CAPITAL MANAGEMENT, LLC 210,500$13,956,00010.09%
Aquilo Capital Management, LLC 700,426$46,438,0005.27%
WEALTH EFFECTS LLC 145,960$9,677,0004.02%
Evolutionary Tree Capital Management, LLC 115,580$7,663,0003.68%
ACUTA CAPITAL PARTNERS, LLC 105,500$6,995,0002.94%
Privium Fund Management B.V. 204,393$13,766,0002.73%
L1 Capital Pty Ltd 292,735$19,408,0002.24%
Avidity Partners Management LP 875,000$58,013,0001.23%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders